Delivery Order SPE2DB24D3014-SPE2DB25FKUVB
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,178.58 to AmerisourceBergen Drug Corp for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units. This firm fixed-price delivery order, awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a routine pharmaceutical procurement from the vendor's Conshohocken, Pennsylvania location. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $3,133.24 to AmerisourceBergen Drug Corp for Potassium Chloride Extended Release 10 MEQ tablets (500-count packaging). This was a competitively awarded, firm fixed-price delivery order with no set-aside designation, completed on April 24, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Potassium Chloride Extended Release 8 MEQ tablets in quantities of 500 units, with a contract ceiling value of $7,195.15. This is a firm fixed-price delivery order with an ultimate completion date of July 25, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for...
- The Defense Logistics Agency awarded a delivery order valued at $2,476.56 to AmerisourceBergen Drug Corp for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units. This contract represents a firm fixed-price delivery order with no set-aside designation, issued competitively on August 5, 2025, with an ultimate completion date of August 6, 2025. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $7,946.59 to AmerisourceBergen Drug Corp for the supply of Potassium Chloride Extended-Release 10 MEQ tablets in quantities of 1,000 units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 18, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Potassium Chloride Extended Release 8 MEQ tablets (500-count packages) with a ceiling value of $4,774.04. This is a firm fixed-price delivery order with an ultimate completion date of June 17, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units. This contract, valued at $22,252.80 with firm fixed pricing, is scheduled for completion by September 19, 2025, and represents a non-set-aside, competitively awarded procurement. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Potassium Chloride Extended Release 20 MEQ tablets in quantities of 500 units, with a contract ceiling value of approximately $8,000. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion on August 21, 2025, and will be performed at AmerisourceBergen's corporate...
- This delivery order, awarded on September 19, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides $4,451.00 for the delivery of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award through open competition. Performance will be completed at AmerisourceBergen's Conshohocken, Pennsylvania facility, with an ultimate completion date of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,391.20 to AmerisourceBergen Drug Corp for Potassium Chloride Extended-Release 10 MEQ tablets in quantities of 1,000 units. This contract award, issued on June 24, 2025, with an ultimate completion date of June 25, 2025, represents a firm fixed price delivery order with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- SPE2DB24D3014Indefinite Delivery Contract
- SPE2DB24D3014-SPE2DB25FKUVBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $9,927.05 for the supply of Potassium Chloride Extended Release 8 MEQ tablets in quantities of 1,000 units. The award, issued on September 25, 2025, represents a firm fixed price delivery order with an ultimate completion date of September 26, 2025. This non-set-aside contract was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and other government entities. The company's portfolio encompasses a broad range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. This delivery order for potassium chloride tablets exemplifies the routine pharmaceutical supply missions executed under the prime IDC, which functions as a flexible global pharmaceutical support vehicle enabling the company to deliver essential medications across multiple therapeutic domains to support military healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.9k | 9/25/25 |